E-LIB Suche - Ergebnisse für: Calderon, Silvia N.

1

Considerations in assessing the abuse potential of psychede..:

Calderon, Silvia N. ; Bonson, Katherine R. ; Reissig, Chad J....
Neuropharmacology. 224 (2023) - p. 109352 , 2023

Link: https://doi.org/10.1016/..

2

Association of partial systemic exposure and abuse potentia..:

Zhao, Liang ; Li, Zhichuan ; Fang, Lanyan...
eClinicalMedicine. 41 (2021) - p. 101135 , 2021

Link: https://doi.org/10.1016/..

3

Concentration-Response Model of Immediate Release Oxycodone..:

Nallani, Srikanth C ; Li, Wenjing ; Calderon, Silvia N...
Pain Medicine. 23 (2021) 7 - p. 1311-1322 , 2021

Link: https://doi.org/10.1093/..

4

A regulatory perspective on the evaluation of hallucinogen ..:

Calderon, Silvia N. ; Hunt, Joshua ; Klein, Michael
Neuropharmacology. 142 (2018) - p. 135-142 , 2018

Link: https://doi.org/10.1016/..

5

Risk based in vitro performance assessment of extended rele..:

Xu, Xiaoming ; Gupta, Abhay ; Al-Ghabeish, Manar..
International Journal of Pharmaceutics. 500 (2016) 1-2 - p. 255-267 , 2016

Link: https://doi.org/10.1016/..

6

Regulatory challenges in evaluating the abuse deterrent pro..:

Calderon, Silvia N. ; Klein, Michael ; Tolliver, J.M.
Drug and Alcohol Dependence. 156 (2015) - p. e34 , 2015

Link: https://doi.org/10.1016/..

7

FDA abuse-deterrent guidance. Assessing new technologies:

Calderon, Silvia N. ; Tolliver, J.M. ; Klein, Michael
Drug and Alcohol Dependence. 146 (2015) - p. e236-e237 , 2015

Link: https://doi.org/10.1016/..

8

Considerations on designs of intranasal studies for abuse-d..:

Chen, Ling ; Calderon, Silvia N. ; Hertz, Sharon H.
Drug and Alcohol Dependence. 156 (2015) - p. e41-e42 , 2015

Link: https://doi.org/10.1016/..

9

Current thinking on the premarketing evaluation of abuse-de..:

Calderon, Silvia N. ; Tolliver, J.M. ; Klein, M.
Drug and Alcohol Dependence. 140 (2014) - p. e24 , 2014

Link: https://doi.org/10.1016/..

10

A regulatory perspective on the abuse potential evaluation ..:

Calderon, Silvia N. ; Klein, Michael
Neuropharmacology. 87 (2014) - p. 97-103 , 2014

Link: https://doi.org/10.1016/..

11

Nonpeptidic Delta (δ) Opioid Agonists and Antagonists of th..:

, In: Topics in Current Chemistry; Chemistry of Opioids,

Calderon, Silvia N. - p. 121-140 , 2010

Link: https://doi.org/10.1007/..

12

Assessment of SNC 80 and Naltrindole Within a Conditioned T..:

Hutchinson, Aurora C ; Simpson, Gregory R ; Randall, Jovita F...
Pharmacology Biochemistry and Behavior. 66 (2000) 4 - p. 779-787 , 2000

Link: https://doi.org/10.1016/..

13

Probes for Narcotic Receptor Mediated Phenomena. 26. Synthe..:

Zhang, Xiaoyan ; Rice, Kenner C. ; Calderon, Silvia N....
Journal of Medicinal Chemistry. 42 (1999) 26 - p. 5455-5463 , 1999

Link: https://doi.org/10.1021/..

14

Opioid peptide receptor studies. 9. Identification of a nov..:

Ni, Qing ; Xu, Heng ; Partilla, John S...
Peptides. 19 (1998) 6 - p. 1079-1090 , 1998

Link: https://doi.org/10.1016/..

15

Probes for Narcotic Receptor-Mediated Phenomena. 25. Synthe..:

Katsura, Yousuke ; Zhang, Xiaoyan ; Homma, Koichi...
Journal of Medicinal Chemistry. 40 (1997) 18 - p. 2936-2947 , 1997

Link: https://doi.org/10.1021/..